Your immune system is extraordinary—a biological defense network that identifies and destroys viruses, bacteria, parasites, and cancer cells whilst ignoring your own healthy tissue. It distinguishes "self" from "non-self" with remarkable precision across trillions of cells. Except when it doesn't. In autoimmune diseases, the immune system mistakenly attacks healthy tissue, causing chronic inflammation and damage. Over 80 different autoimmune conditions affect approximately 4 million people in the UK—conditions ranging from relatively manageable to severely disabling, from common to rare, but all sharing the fundamental problem of immune self-attack.
These diseases include type 1 diabetes (immune attack on insulin-producing pancreatic cells), rheumatoid arthritis (attack on joint tissue), multiple sclerosis (attack on nerve sheaths), and many others. What causes this catastrophic failure of self-recognition? Why are autoimmune diseases increasing in prevalence? And why do they affect women three times more often than men? These questions are driving some of the most intensive research in immunology and medicine.
How the Immune System Normally Works
Understanding autoimmunity requires understanding normal immune function. The immune system has two main components:
Innate immunity provides immediate, non-specific defense. Physical barriers (skin, mucus), chemical barriers (stomach acid, antimicrobial enzymes), and cells that engulf pathogens (macrophages, neutrophils) operate continuously. Innate immunity doesn't distinguish specific threats—it responds to general danger signals.
Adaptive immunity learns to recognize specific threats and remembers them. B cells produce antibodies—proteins that bind to specific molecular targets. T cells come in varieties: helper T cells coordinate immune responses, cytotoxic T cells kill infected cells, and regulatory T cells suppress excessive responses. The adaptive immune system can recognize billions of different molecular structures through a remarkable genetic mechanism generating diverse antibody and T cell receptors.
Crucially, developing immune cells undergo "education" in the thymus and bone marrow. Cells that strongly react to the body's own proteins are eliminated—a process called negative selection. This is how the immune system learns self-tolerance: potentially self-reactive cells are deleted before they enter circulation.
Most of the time, this system works perfectly. Autoimmune disease represents a failure of this tolerance mechanism.
What Goes Wrong in Autoimmunity
Autoimmune diseases arise when self-reactive immune cells escape negative selection or when regulatory mechanisms fail. The triggers are complex and incompletely understood but involve genetic susceptibility, environmental factors, and chance.
Genetic factors are significant. Having a close relative with an autoimmune disease increases your risk. Certain genetic variants—particularly in genes controlling immune function like HLA (human leukocyte antigen) genes—associate strongly with autoimmune risk. But genetics alone don't determine outcome: identical twins have only 30-50% concordance for most autoimmune diseases, meaning environment and chance also matter significantly.
Molecular mimicry is one proposed mechanism. Some bacterial or viral proteins resemble human proteins. Immune responses to infection might accidentally target similar human proteins—like attacking both the invader and a lookalike innocent bystander. Group A Streptococcus bacteria, for instance, have proteins similar to heart tissue proteins. In some individuals, strep throat triggers rheumatic fever—autoimmune attack on the heart—through molecular mimicry.
Epitope spreading occurs when initial tissue damage (from infection or injury) releases self-proteins that the immune system hasn't previously encountered in that form. This can activate self-reactive immune cells, which then spread the attack to additional self-proteins—expanding the autoimmune response.
Loss of regulatory control can occur if regulatory T cells (which suppress excessive immune responses) fail or if inflammatory signals override regulation. The balance between activation and suppression is delicate; disruption leads to either immunodeficiency (too little immune activity) or autoimmunity (too much, misdirected activity).
Common Autoimmune Diseases
Type 1 Diabetes: The immune system destroys insulin-producing beta cells in the pancreas. Without insulin, cells cannot absorb glucose from blood, causing dangerous high blood sugar. Treatment requires lifelong insulin replacement. T1D typically develops in childhood or young adulthood and affects approximately 400,000 people in the UK.
Rheumatoid Arthritis: Immune attack on joint linings causes inflammation, pain, and eventually joint destruction. Affects approximately 400,000 UK adults, more women than men. Modern treatments (disease-modifying antirheumatic drugs and biologics) can slow progression significantly.
Multiple Sclerosis: The immune system attacks myelin—the insulating sheath around nerve fibers in the brain and spinal cord. This disrupts nerve signals, causing symptoms ranging from numbness and vision problems to paralysis. MS affects approximately 130,000 people in the UK.
Lupus (Systemic Lupus Erythematosus): A systemic disease where antibodies attack multiple tissues including joints, skin, kidneys, and blood cells. Symptoms vary widely between individuals. Lupus predominantly affects women of childbearing age.
Coeliac Disease: Immune reaction to gluten (a protein in wheat, barley, rye) damages the small intestine's lining, preventing nutrient absorption. Treatment is strict gluten avoidance. Affects approximately 1 in 100 people in the UK.
Hashimoto's Thyroiditis: Immune attack on the thyroid gland causes hypothyroidism—insufficient thyroid hormone production, leading to fatigue, weight gain, and metabolic slowdown. Very common—affecting perhaps 5% of UK adults, mostly women.
Why Women Are More Affected
Approximately 80% of autoimmune disease patients are women—a striking disparity demanding explanation. Several factors likely contribute:
Hormones: Estrogen influences immune function, generally enhancing immune responses (useful for fighting infections but potentially increasing autoimmune risk). Many autoimmune diseases show symptom fluctuations with menstrual cycle, pregnancy, and menopause—times of hormonal change.
X chromosome genes: Many immune-related genes reside on the X chromosome. Women have two X chromosomes; men have one. This creates complex gene dosage effects. Additionally, X-inactivation (where one X chromosome in female cells is silenced) is imperfect—some immune genes on the "inactive" X remain partially active, potentially skewing immune responses.
Microchimerism: During pregnancy, fetal cells cross the placenta and can persist in maternal circulation for decades. These foreign cells might trigger immune responses that sometimes target self-tissue through molecular similarity.
Environmental and social factors: Women may have different environmental exposures or seek medical care earlier, potentially influencing diagnosis rates versus actual incidence.
The full explanation remains elusive but is a major research focus given the clinical impact.
The Hygiene Hypothesis and Modern Increases
Autoimmune disease prevalence has increased significantly in high-income countries over the past 50 years. The hygiene hypothesis proposes that reduced childhood exposure to infections, due to improved sanitation, antibiotics, and smaller families, leads to inadequate immune system training. The immune system, lacking sufficient microbial challenges, becomes oversensitive and misdirects responses toward self or harmless environmental antigens (allergens).
Supporting evidence includes: autoimmune diseases are more common in urban versus rural populations, in high-income versus low-income countries, and in children growing up in more sanitary conditions. However, the hypothesis remains debated—increased diagnosis might partly explain apparent increases.
Microbiome disruption likely contributes. The gut microbiome trains and regulates immune function. Antibiotic use, Western diets low in fiber, and reduced microbial diversity might impair immune regulation, increasing autoimmune risk. This connects to the microbiome research discussed in August's deep dive.
Treatment Approaches
Most autoimmune diseases cannot be cured but can be managed:
Immunosuppression: Corticosteroids and other immunosuppressive drugs reduce immune activity, controlling symptoms but also increasing infection risk.
Targeted therapies: Biologics (engineered antibodies) target specific immune molecules or cells. For example, TNF-alpha inhibitors block a key inflammatory signal and revolutionized rheumatoid arthritis treatment.
Hormone replacement: For thyroid or pancreatic destruction, replacing missing hormones (thyroxine, insulin) manages symptoms.
Dietary modification: For coeliac disease, strict gluten avoidance eliminates immune trigger.
Emerging approaches: Research on regulatory T cell therapy, resetting the immune system through stem cell transplantation, and antigen-specific tolerance (teaching the immune system to tolerate specific self-proteins) shows promise.
Living with Autoimmunity
Autoimmune diseases are typically chronic, requiring long-term management. Many are "invisible illnesses"—individuals may appear healthy whilst experiencing significant symptoms (pain, fatigue, brain fog). This invisibility can complicate social understanding and support.
The unpredictability is challenging—symptoms often fluctuate between flares (active disease) and remission (minimal symptoms). Stress, infections, hormonal changes, and other factors can trigger flares, though often unpredictably.
Support networks, patient organizations, and improved medical management have transformed outcomes for many autoimmune conditions. Conditions once severely disabling (like rheumatoid arthritis) can often be controlled effectively with modern treatments. Research continues intensively—autoimmunity represents one of medicine's major frontiers.
Understanding that autoimmune diseases result from immune system dysregulation rather than moral failing, lifestyle choices, or psychological factors matters profoundly. These are biological diseases with biological mechanisms, deserving medical treatment and social understanding, not judgment.
